RESEARCH TRIANGEL PARK, N.C. – Kay Wagoner, president and chief executive officer of drug development firm Icagen, received an honor from the Women in Bio organization last week in Washington, D.C.
Icagen recently raised $22 million through a private stock placement. Wagoner launched the company in 1992.
"I was surprised and honored to receive recognition from the Women in Bio organization,” Wagoner said in a statement.
“Organizations such as this support professional development for individuals seeking to advance their careers in the bioscience industry,” she added. “I have been very fortunate to work with a talented group of people at Icagen, who are responsible in large measure for the success of our company."